The Minnesota House and Senate have reached an agreement over two new programs that will make insulin more affordable to uninsured and low-income residents.
On April 8, via virtual conferencing, the legislative bodies reviewed a proposal that looked at different versions of insulin bills passed before the COVID-19 shut down the state. On April 14, when the House and Senate reconvene, the bills are expected to be acted on.
The proposal creates a program that would provide a one-time, emergency supply with a monthly cost capped at $35. The program applies to those without insurance, or those who have insurance, but pay more than $75 per month for their insulin. Intended for patients in crisis and those who need insulin immediately, the program can be accessed only one-time a year.
The bill would also create a longer-term program that would provide a 90-day supply of insulin for no more than $50 for those earning less than 400 percent of the federal poverty level. The program requires insulin manufacturers to provide insulin to the program free of charge, or face a $200,000 fine.
The bill allocated money from the state’s Health Care Access Fund to pay for the administration and promotion of the programs.